February 19, 2024

Body Composition in Anti-Obesity Medication Trials—Beyond Scales

Key Points

Key points are not available for this paper at this time.

Abstract

This Viewpoint contends that focusing only on weight loss as the primary weight medication end point is an inaccurate measure of medication efficacy for both patients and clinicians.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Agarwal et al. (Mon,) studied this question.

synapsesocial.com/papers/68e78822b6db6435876fb13d — DOI: https://doi.org/10.1001/jamainternmed.2023.7733

Authors

Ank A Agarwal

Stanford University

Aditya Narayan

Stanford University

Fatima Cody Stanford

University College Dublin

Journals

JAMA Internal Medicine

Actions

Institutions

Stanford University

Massachusetts General Hospital

Palo Alto University

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Body Composition in Anti-Obesity Medication Trials—Beyond Scales

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Also consider

Also consider